FLXN
Sector: Manufacturing
Industry: Pharmaceutical Products
(%)
Volume:
52 week range:
-
Market Cap:
458.931M
Company Description:
Flexion Therapeutics, Inc. is a pharmaceutical company focuses on development and commercialization of novel, local therapies. It specializes in treatment of patients with musculoskeletal conditions including osteoarthritis, a type of degenerative arthritis. Its products include Zilretta. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.